Deteriorated portal flow may cause liver failure in patients with hepatocellular carcinoma being treated with sorafenib

Akihiro Yamasaki, Narihiro Umeno, Shigeru Harada, Kosuke Tanaka, Masaki Kato, Kazuhiro Kotoh

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Deteriorated portal flow may cause liver failure in patients with hepatocellular carcinoma being treated with sorafenib'. Together they form a unique fingerprint.

Medicine & Life Sciences